CONMED CORP (CNMD) Stock Price, Forecast & Analysis

NYSE:CNMD • US2074101013

41.8 USD
+0.13 (+0.31%)
At close: Feb 13, 2026
41.8 USD
0 (0%)
After Hours: 2/13/2026, 8:04:00 PM

CNMD Key Statistics, Chart & Performance

Key Statistics
Market Cap1.29B
Revenue(TTM)1.37B
Net Income(TTM)64.32M
Shares30.97M
Float30.79M
52 Week High64.87
52 Week Low35.37
Yearly Dividend0.8
Dividend Yield1.97%
EPS(TTM)4.61
PE9.07
Fwd PE9.23
Earnings (Next)04-28
IPO1987-07-23
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
CNMD short term performance overview.The bars show the price performance of CNMD in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20

CNMD long term performance overview.The bars show the price performance of CNMD in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40 -50

The current stock price of CNMD is 41.8 USD. In the past month the price decreased by -1.76%. In the past year, price decreased by -33.81%.

CONMED CORP / CNMD Daily stock chart

CNMD Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to CNMD. When comparing the yearly performance of all stocks, CNMD is a bad performer in the overall market: 82.07% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating
CNMD Full Technical Analysis Report

CNMD Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to CNMD. Both the profitability and the financial health of CNMD get a neutral evaluation. Nothing too spectacular is happening here.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
CNMD Full Fundamental Analysis Report

CNMD Financial Highlights

Over the last trailing twelve months CNMD reported a non-GAAP Earnings per Share(EPS) of 4.61. The EPS increased by 10.82% compared to the year before.


Industry RankSector Rank
PM (TTM) 4.77%
ROA 2.77%
ROE 6.38%
Debt/Equity 0.85
Chartmill High Growth Momentum
EPS Q2Q%6.72%
Sales Q2Q%7.88%
EPS 1Y (TTM)10.82%
Revenue 1Y (TTM)5.18%
CNMD financials

CNMD Forecast & Estimates

12 analysts have analysed CNMD and the average price target is 49.57 USD. This implies a price increase of 18.59% is expected in the next year compared to the current price of 41.8.

For the next year, analysts expect an EPS growth of -1.76% and a revenue growth 0.29% for CNMD


Analysts
Analysts73.33
Price Target49.57 (18.59%)
EPS Next Y-1.76%
Revenue Next Year0.29%
CNMD Analyst EstimatesCNMD Analyst Ratings

CNMD Ownership

Ownership
Inst Owners114.3%
Ins Owners0.29%
Short Float %7.55%
Short Ratio3.66
CNMD Ownership

CNMD Latest News, Press Relases and Analysis

All CNMD news

CNMD Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
ABT ABBOTT LABORATORIES19.62193.832B
ISRG INTUITIVE SURGICAL INC47.53169.664B
SYK STRYKER CORP24.21139.908B
BSX BOSTON SCIENTIFIC CORP21.34109.921B
BDX BECTON DICKINSON AND CO11.1650.66B
IDXX IDEXX LABORATORIES INC42.4849.283B
EW EDWARDS LIFESCIENCES CORP25.5244.358B
RMD RESMED INC20.5735.869B
GEHC GE HEALTHCARE TECHNOLOGY1635.845B
DXCM DEXCOM INC27.7325.383B

About CNMD

Company Profile

CNMD logo image CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. The company is headquartered in Largo, Florida. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.

Company Info

CONMED CORP

11311 Concept Boulevard

Largo FLORIDA 33773 US

CEO: Curt R. Hartman

Employees: 3900

CNMD Company Website

CNMD Investor Relations

Phone: 17272142974

CONMED CORP / CNMD FAQ

What does CONMED CORP do?

CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. The company is headquartered in Largo, Florida. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.


Can you provide the latest stock price for CONMED CORP?

The current stock price of CNMD is 41.8 USD. The price increased by 0.31% in the last trading session.


Does CONMED CORP pay dividends?

CONMED CORP (CNMD) has a dividend yield of 1.97%. The yearly dividend amount is currently 0.8.


What is the ChartMill rating of CONMED CORP stock?

CNMD has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


What is the Price/Earnings (PE) ratio of CONMED CORP (CNMD)?

The PE ratio for CONMED CORP (CNMD) is 9.07. This is based on the reported non-GAAP earnings per share of 4.61 and the current share price of 41.8 USD.


Can you provide the upcoming dividend date for CONMED CORP?

The next ex-dividend date for CONMED CORP (CNMD) is September 15, 2025.


Can you provide the market cap for CONMED CORP?

CONMED CORP (CNMD) has a market capitalization of 1.29B USD. This makes CNMD a Small Cap stock.